Searched for
CANCER TREATMENT COSTS
Rs 1 lakh to Rs 30,000: Cancer immunotherapy gets cheaper, but will patients get the price benefit?Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% r...- From mercury to gold? This San Francisco startup claims it can produce yellow metal at willSan Francisco-based startup Marathon Fusion claims to have converted mercury into stable gold using fusion-generated neutrons, at a rate 10...
- Hospitals overcharge patients upto 700% on medicines while India makes some of the world’s lowest priced drugs: Centre admits to SCGovt has told Supreme Court that hospitals overcharging patients for medicines and medical consumables is a malpractice. Its affidavit cite...
- Alaska ferry fares covered just 31% of operating costs over 10 years, while the state put in $82.6 million a year to keep coastal communities connectedAlaska's ferry system serves as a lifeline for 28 isolated communities, offering the only reliable transportation year-round. Currently, ti...
- The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reachFor millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...
- Eyes now on Viksit, net zero later: Can India achieve high-income status by 2047 without compromising on climate promises?India aims to achieve a high-income economy status by 2047, requiring substantial economic growth and investment. However, ambitious climat...
- LIC reveals details of its 3 new plans: Check benefits of New Jeevan Dhara-II, Health Shield and New Cancer CoverLife Insurance Corporation of India is set to launch three new insurance products on October 19, 2026. These offerings, namely New Jeevan D...
- Protect patients and patents smartlyThe Kerala High Court has stressed the importance of making cancer medicines like ribociclib more affordable for patients. The Government o...
- Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
- Ministry of Science signs MoU with Peptris for collab in AI-based drug discovery and developmentThe Ministry of Science has entered into a partnership with Peptris Technologies to bolster drug development under the initiative called VI...
- Office critical illness cover: How well does it protect employees and their families?The distinction matters for how HR teams design the benefit. A fixed benefit CI policy addresses income replacement and non medical costs t...
- Roche calls for global healthcare overhaul to tackle disease burdenRoche highlights the urgent need for a transformation in global healthcare to effectively tackle chronic diseases. Jorg Rupp pointed out th...
- Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullishHospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...
- Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...
- Lance Armstrong net worth, salary, earnings, wealth: Rise and fall of once iconic American cyclist, face of prestigious Tour de France and investment lessons from Olympic medalistLance Armstrong during his peak had signed major endorsements with Nike, Oakley, Trek and Anheuser Busch. Armstrong said that he lost about...
- Wall Street’s $10 billion India hospital bet sparks a fight over billsWall Street has poured about $10 billion into Indian hospital chains over the past five years, with investors including Blackstone, KKR, TP...
- Karnataka flags 52x mark-up on cancer drugs, seeks Centre's interventionKarnataka conducted inspections revealing significant price disparities between hospital procurement and patient billing for cancer drugs a...
- SC seeks 16% MRP cap on medicines, flags huge cancer drug markupsThe Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant marku...
- In Iowa, soaring cancer rates emerge as a key midterms issueCancer has emerged as an unusual bipartisan campaign issue in Iowa’s midterm races as the state confronts the second-highest cancer rate in...
- India needs five-year policy to make precision cancer care afforable, says expertIndia needs a five-year roadmap to expand access to genomic testing and targeted cancer therapies for lower-income patients, oncologist Dr ...
Load More
